$VASO Cashflow Statement | Understand Stock

$VASO

$0.31 +$0.02 (7.81%) Close

$VASO Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities
Net income
Adjustments to reconcile net income to net cash provided by operating activities
Depreciation and amortization
Deferred income taxes
Loss (gain) from investment in EECP Global
Gain on sale of equity in EECP Global
Gain on forgiveness of PPP loan
Loss from investment in EECP Global
Gain on sale of subsidiary
Impairment of goodwill
Provision for credit losses and commission adjustments
Write-down of inventory
Write-off of Achari loan
Share-based compensation

Changes in operating assets and liabilities:
Accounts and other receivables
Due from related parties
Inventories
Deferred commission expense
Prepaid expenses and other current assets
Other assets, net
Accounts payable
Accrued commissions
Accrued expenses and other liabilities
Sales tax payable
Income taxes payable
Due to related party
Deferred revenue
Other long-term liabilities
Net cash provided by operating activities
Cash flows from investing activities
Redemption (purchases) of short-term investments
Proceeds from sale of equity in EECP Global
Purchases of equipment and software
Loan to Achari
Purchases of short-term investments
Redemption of short-term investments
Proceeds from sale of VasoHealthcare IT Corp.

Net cash (used in) provided by investing activities
Cash flows from financing activities
Repayment on revolving lines of credit
Payroll taxes paid by withholding shares
Repayment of notes payable - related parties
Proceeds from note payable
Repayment of notes payable and finance lease obligations

Net cash provided by (used in) financing activities
Effect of exchange rate differences on cash and cash equivalents
NET INCREASE IN CASH AND CASH EQUIVALENTS
Cash and cash equivalents - beginning of period
Cash and cash equivalents - end of period
Cash and cash equivalents - beginning of year
Cash and cash equivalents - end of year
SUPPLEMENTAL DISCLOSURE OF CASH INFORMATION
Interest paid
Income taxes paid
SUPPLEMENTAL SCHEDULE OF NON-CASH INVESTING AND FINANCING ACTIVITIES
Initial recognition of operating lease right of use asset and liability
Equipment acquired through note payable
Transfer of fixed assets to inventory

Comments